-
Start Preamble
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 20, 2002, Syva Company, Dade Behring Inc., Regulatory Affairs Department E1-310, 20400 Mariana Avenue, Cupertino, California, 95014, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Tetrahydrocannabinols (7370) I Ecogonine (9180) II Morphine (9300) II The firm plans to produce bulk products used for the manufacture of reagents and drug calibrator/controls, DEA exempt products.
Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Start Printed Page 17406Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Drug Operations Section, Domestic Drug Unit (ODOD) and must be filed no later than 60 days from publication.
Start SignatureDated: March 21, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 03-8584 Filed 4-8-03; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 04/09/2003
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 03-8584
- Pages:
- 17405-17406 (2 pages)
- PDF File:
- 03-8584.pdf